{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:28:35Z","timestamp":1793179715626,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaci.2026.05.014","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:39:46Z","timestamp":1779925186000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Practice parameter for inborn errors of immunity: What is new in the 2025 update"],"prefix":"10.1016","volume":"158","author":[{"given":"Javier","family":"Chinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Horner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.05.014_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2025.10.026","volume":"136","author":"Orange","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1081-1206(10)63442-4","article-title":"Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI)","volume":"76","author":"Shearer","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)61142-8","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaci.2026.05.014_bib5","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaci.2026.05.014_bib6","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.jaip.2021.09.035","article-title":"Translating evidence to optimize patient care using GRADE","volume":"9","author":"Chu","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.05.014_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","article-title":"The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)","volume":"143","author":"Dvorak","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cei\/uxad001","article-title":"Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients","volume":"212","author":"Hsu","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2026.05.014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2025.101613","article-title":"The ClinGen Severe Combined Immunodeficiency Disease Variant Curation Expert Panel: specifications for classification of variants in ADA, DCLRE1C, IL2RG, IL7R, JAK3, RAG1, and RAG2","volume":"28","author":"Jacovas","year":"2026","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2026.05.014_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(23)00731-6","article-title":"Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium","volume":"402","author":"Thakar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2026.05.014_bib12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2300","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017","volume":"143","author":"Amatuni","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2026.05.014_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.iac.2020.03.002","article-title":"The importance of primary immune deficiency registries: the United States Immunodeficiency Network Registry","volume":"40","author":"Lopes","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2026.05.014_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global systematic review of primary immunodeficiency registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10875-019-00691-8","article-title":"Defining polysaccharide antibody deficiency: measurement of anti-pneumococcal antibodies and anti-Salmonella typhi antibodies in a cohort of patients with recurrent infections","volume":"40","author":"Bucciol","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib16","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/S2214-109X(24)00055-X","article-title":"Typhoid conjugate vaccines: a step towards typhoid control","volume":"12","author":"Shakya","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jaci.2026.05.014_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3389\/fimmu.2019.00986","article-title":"A critical view of specific antibody deficiencies","volume":"10","author":"Sorensen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib18","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250007","article-title":"Inborn errors of immunity: manifestation, treatment, and outcome\u2014an ESID registry 1994-2024 report on 30,628 patients","volume":"1","author":"Kindle","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaci.2026.05.014_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2249.2012.04594.x","article-title":"Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy","volume":"169","author":"Orange","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib20","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jaci.2018.08.010","article-title":"Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies","volume":"142","author":"Marsh","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10875-024-01778-7","article-title":"Description of BCG and tuberculosis disease in a cohort of 79 patients with chronic granulomatous disease","volume":"44","author":"Le\u00f3n-Lara","year":"2024","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2022.12.813","article-title":"The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease","volume":"152","author":"Smits","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-025-01873-3","article-title":"Multi-year registry study of elapegademase treatment in patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) requiring enzyme replacement therapy","volume":"45","author":"Dorsey","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaci.2021.04.039","article-title":"Therapeutic options for CTLA-4 insufficiency","volume":"149","author":"Egg","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","article-title":"Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients","volume":"9","author":"Fr\u00e9mond","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.05.014_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jaci.2023.09.032","article-title":"Interim analysis: open-label extension study of leniolisib in patient with APDS","volume":"153","author":"Rao","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.05.014_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103421","article-title":"Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study","volume":"153","author":"Bustaffa","year":"2025","journal-title":"J Autoimmun"}],"updated-by":[{"DOI":"10.1016\/j.jaci.2026.08.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926003696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926003696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:19:31Z","timestamp":1785921571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926003696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0091674926003696"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.05.014","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice parameter for inborn errors of immunity: What is new in the 2025 update","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}